215 related articles for article (PubMed ID: 38348020)
1. Co-Morbid Hypothyroidism and Liver Dysfunction: A Review.
Yorke E
Clin Med Insights Endocrinol Diabetes; 2024; 17():11795514241231533. PubMed ID: 38348020
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.
Eshraghian A; Hamidian Jahromi A
World J Gastroenterol; 2014 Jul; 20(25):8102-9. PubMed ID: 25009382
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand.
Gor R; Siddiqui NA; Wijeratne Fernando R; Sreekantan Nair A; Illango J; Malik M; Hamid P
Cureus; 2021 May; 13(5):e14858. PubMed ID: 34104598
[TBL] [Abstract][Full Text] [Related]
4. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents.
Kaltenbach TE; Graeter T; Oeztuerk S; Holzner D; Kratzer W; Wabitsch M; Denzer C
Pediatr Obes; 2017 Feb; 12(1):67-74. PubMed ID: 26877190
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know.
Bikeyeva V; Abdullah A; Radivojevic A; Abu Jad AA; Ravanavena A; Ravindra C; Igweonu-Nwakile EO; Ali S; Paul S; Yakkali S; Teresa Selvin S; Thomas S; Hamid P
Cureus; 2022 Aug; 14(8):e28052. PubMed ID: 36127957
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.
Jaruvongvanich V; Sanguankeo A; Upala S
Eur Thyroid J; 2017 Jul; 6(4):208-215. PubMed ID: 28868261
[TBL] [Abstract][Full Text] [Related]
7. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015.
Lee J; Ha J; Jo K; Lim DJ; Lee JM; Chang SA; Kang MI; Cha BY; Kim MH
Sci Rep; 2018 Oct; 8(1):15145. PubMed ID: 30310098
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease.
Vidal-Cevallos P; Murúa-Beltrán Gall S; Uribe M; Chávez-Tapia NC
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834051
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital.
Augustine S; Harshitha R; Sangayya Hiremath R; Anil Kumar H; Prajwal KC
Cureus; 2023 Apr; 15(4):e37094. PubMed ID: 37153275
[TBL] [Abstract][Full Text] [Related]
10. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders.
Feisa SV; Chopei IV
Wiad Lek; 2018; 71(2 pt 1):261-264. PubMed ID: 29729151
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD.
Mavromati M; Jornayvaz FR
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884625
[TBL] [Abstract][Full Text] [Related]
12. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease.
Fröhlich E; Wahl R
Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005590
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms.
Ferrandino G; Kaspari RR; Spadaro O; Reyna-Neyra A; Perry RJ; Cardone R; Kibbey RG; Shulman GI; Dixit VD; Carrasco N
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9172-E9180. PubMed ID: 29073114
[TBL] [Abstract][Full Text] [Related]
14. Thyroid dysfunction and non-alcoholic fatty liver disease.
Efstathiadou ZA; Kita MD; Polyzos SA
Minerva Endocrinol; 2018 Sep; 43(3):367-376. PubMed ID: 28181781
[TBL] [Abstract][Full Text] [Related]
15. Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver.
Yao X; Hou S; Zhang D; Xia H; Wang YC; Jiang J; Yin H; Ying H
Cell Biosci; 2014; 4():38. PubMed ID: 25105012
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Floria M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824723
[TBL] [Abstract][Full Text] [Related]
17. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
Zhaldak DA; Melekhovets OK; Orlovskyi VF
Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
Tahara K; Akahane T; Namisaki T; Moriya K; Kawaratani H; Kaji K; Takaya H; Sawada Y; Shimozato N; Sato S; Saikawa S; Nakanishi K; Kubo T; Fujinaga Y; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Ogawa H; Takagi H; Ishida K; Mitoro A; Yoshiji H
JGH Open; 2020 Jun; 4(3):400-404. PubMed ID: 32514444
[TBL] [Abstract][Full Text] [Related]
19. Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany.
Labenz C; Kostev K; Armandi A; Galle PR; Schattenberg JM
United European Gastroenterol J; 2021 Sep; 9(7):829-836. PubMed ID: 34288580
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study.
Almomani A; Hitawala AA; Kumar P; Alqaisi S; Alshaikh D; Alkhayyat M; Asaad I
World J Hepatol; 2022 Mar; 14(3):551-558. PubMed ID: 35582287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
